Drug
LY3484356
LY3484356 is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
100%(3 trials)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
active_not_recruiting240%
completed360%
Recent Activity
2 active trials
Showing 5 of 5
active_not_recruitingphase_1
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
NCT05509790
completedphase_1
A Study of LY3484356 in Healthy Female Participants
NCT04840888
completedphase_1
A Study of [¹⁴C]-LY3484356 in Healthy Female Participants
NCT04991766
completedphase_1
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery
NCT04647487
active_not_recruitingphase_1
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548
Clinical Trials (5)
Showing 5 of 5 trials
NCT05509790Phase 1
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
NCT04840888Phase 1
A Study of LY3484356 in Healthy Female Participants
NCT04991766Phase 1
A Study of [¹⁴C]-LY3484356 in Healthy Female Participants
NCT04647487Phase 1
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery
NCT04188548Phase 1
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5